300485 赛升药业
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-2.9043.0236.18713.3005.655
总资产报酬率 ROA (%)-2.7512.8625.87412.5855.345
投入资产回报率 ROIC (%)-2.8222.9366.06413.1725.632

边际利润分析
销售毛利率 (%)65.86570.42676.63882.66883.793
营业利润率 (%)-37.55725.54434.66641.77716.442
息税前利润/营业总收入 (%)-38.11825.41434.60240.70415.169
净利润/营业总收入 (%)-31.65420.23027.58837.60313.826

收益指标分析
经营活动净收益/利润总额(%)-15.436-33.6269.43024.09681.100
价值变动净收益/利润总额(%)116.704131.03383.30972.53322.865
营业外收支净额/利润总额(%)0.1940.349-0.0080.006-0.349

偿债能力分析
流动比率 (X)20.32826.30017.62117.29810.932
速动比率 (X)19.24324.21916.43215.9079.763
资产负债率 (%)4.6444.2684.4023.4850.047
带息债务/全部投入资本 (%)0.1880.1720.2530.3740.384
股东权益/带息债务 (%)51,784.68556,495.61338,469.30426,389.74825,901.404
股东权益/负债合计 (%)2,036.4602,222.3702,147.6772,737.1661,987.146
利息保障倍数 (X)78.213-115.483-563.178-37.840-12.469

营运能力分析
应收账款周转天数 (天)41.19346.43140.96435.35544.262
存货周转天数 (天)241.592250.518222.522278.408333.736